Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism

Tissue Antigens

Volumn 48, Issue 5, 1996, Pages 509-518

  Galocha, B ^a   Lamas, J R ^a   Villadangos, J A ^a   Albar, J P ^b   Lopez De Castro J A ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Ankylosing spondylitis; B*2704; B*2706; HLA B27; Peptide binding

Indexed keywords

ALIPHATIC COMPOUND; AROMATIC COMPOUND; HLA B27 ANTIGEN; LEUCINE; PHENYLALANINE; PROTEIN SUBUNIT; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANKYLOSING SPONDYLITIS; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENETIC POLYMORPHISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; HLA-B27 ANTIGEN; HUMANS; MOLECULAR MIMICRY; MUTATION; PEPTIDES; POLYMORPHISM, GENETIC; SPONDYLITIS, ANKYLOSING; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030475570     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02664.x     Document Type: Article

References (41)

1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973: 1: 904-907.
2. Kingsley G, Sieper J. Current perspectives in reactive arthritis. Immunol Today 1993: 14: 387-391.
3. Lopez de Castro JA. Structure, function, and disease association of HLA-B27. Curr Opin Rheumatol 1994: 6: 371-377.
4. Lopez de Castro JA. Structural polymorphism and function of HLA-B27. Curr Opin Rheumatol 1995: 7: 270-278.
5. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990: 11: 137-142.
6. Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993: 342: 646-650.
7. Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995: 7: 263-269.
8. Breur-Vriesendorp BS, Dekker Saeys AJ, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987: 46: 353-356
9. Lopez-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995: 45: 169-176.
10. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1991: 337: 640-642.
11. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995: 25: 3199-3201.
12. Rojo S, Garcia F, Villadangos JA, Lopez de Castro JA. Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B. J Exp Med 1993: 177: 613-620.
13. Rotzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee HG. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 1994: 39: 74-77.
14. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991: 353: 326-329.
15. Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991: 353: 321-325.
16. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992: 70: 1035-1048.
17. Parker KC, Biddison WE, Coligan JE. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding. Biochemistry 1994: 33: 7736-7743.
18. Villadangos JA, Galocha B, Garcia F, Albar JP, Lopez de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur J Immunol 1995: 25: 2370-2377
19. Lopez D, Garcia Hoyo R, Lopez de Castro JA. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy. J Immunol 1994: 152: 5557-5571.
20. Vega MA, Wallace L, Rojo S, Bragado R, Aparicio P, Lopez de Castro JA. Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes. J Immunol 1985: 135: 3323-3332.
21. Rudwaleit M, Bowness P, Wordsworth P. The nucleotide sequence of HLA-B*2704 reveals a new amino acid substitution in exon 4 which is also present in HLA-B*2706. Immunogenetics 1996: 43: 160-162.
22. Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 1992: 257: 919-927.
23. Vega MA, Bragado R, Ivanyi P, Pelaez JL, Lopez de Castro JA. Molecular analysis of a functional subtype of HLA-B27. A possible evolutionary pathway for HLA-B27 polymorphism. J Immunol 1986: 137: 3557-3565.
24. Vilches C, de Pablo R, Kreisler M. Nucleotide sequence of HLA-B*2706. Immunogenetics 1994: 39: 219.
25. Ljunggren HG, Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985: 162: 1745-1759.
26. Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989: 340: 443-448.
27. Ljunggren HG, Stam NJ, Ohlen C et al. Empty MHC class I molecules come out in the cold. Nature 1990: 346: 476-480.
28. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum Immunol 1982: 5: 49-59.
29. Brodsky FM, Bodmer WF, Parham P. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol 1979: 9: 536-545.
30. Calvo V, Rojo S, Lopez D, Galocha B, Lopez de Castro JA. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990: 144: 4038-4045.
31. Villadangos JA, Galocha B, Lopez de Castro JA. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J Immunol 1994: 152: 2317-2323.
32. Benjamin RJ, Madrigal JA, Parham P. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 1991: 351: 74-77.
33. Tanigaki N, Fruci D, Vigneti E, Starace G, Rovero P, Londei M, Butler RH, Tosi R. The peptide binding specificity of HLA-B27 subtypes. Immunogenetics 1994: 40: 192-198.
34. Huczko EL, Bodnar WM, Benjamin D et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 1993: 151: 2572-2587.
35. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995: 41: 178-228.
36. Fiorillo MT, Greco G, Sorrentino R. The Asp116-His116 substitution in a novel HLA-B27 subtype influences the acceptance of the peptide C-terminal anchor. Immunogenetics 1995: 41: 38-41.
37. Lopez D, Rojo S, Calvo V, Lopez de Castro JA. Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity. J Immunol 1992: 148: 996-1002.
38. Villadangos JA, Galocha B, Garcia Hoyo R, Lopez D, Garcia F, Lopez de Castro JA. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705. Eur J Immunol 1994: 24: 2548-2555.
39. Parham P, Adams EJ, Arnett KL 1995 The origins of HLA-A, B,C polymorphism. Immunol Rev 143: 141-80
40. Fruci D, Butler RH, Greco G et al. Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes. Immunogenetics 1995: 42: 123-128.
41. Choo SY, Fan LA, Hansen JA. A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain. J Immunol 1991: 147: 174-180.